8月11日 - ** 制药公司传奇生物(LEGN.O)的股价在盘前交易中上涨5.1%,至21.70美元
** 据伦敦证券交易所集团(LSEG)汇编的数据,Legend Biotech第二季度营收为3.875亿美元,高于分析师平均预期的3.558亿美元
** 第二季度调整后每股收益为16美分,高于预期的7美分
** 公司报告称,截至6月30日,其现金及现金等价物和定期存款约为9.65亿美元
** 截至上一交易日收盘,该股年内累计跌幅约为5%
8月11日 - ** 制药公司传奇生物(LEGN.O)的股价在盘前交易中上涨5.1%,至21.70美元
** 据伦敦证券交易所集团(LSEG)汇编的数据,Legend Biotech第二季度营收为3.875亿美元,高于分析师平均预期的3.558亿美元
** 第二季度调整后每股收益为16美分,高于预期的7美分
** 公司报告称,截至6月30日,其现金及现金等价物和定期存款约为9.65亿美元
** 截至上一交易日收盘,该股年内累计跌幅约为5%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.